PGM3 and myeloid neoplasm: The prevalence of germline predisposition to myeloid neoplasm in young-onset MDS was approximately 16%, largely associated with primary immunodeficiencies, and we have demonstrated the PGM3 variants as the cause of germline predisposition for the first time.